Selected research
Industry Research
Organ Tumor Chip Industry Research Report 2026
Market perspective
The global Organ Tumor Chip market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Organ Tumor Chip is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Organ Tumor Chip is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Organ Tumor Chip is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Organ Tumor Chip include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Organ Tumor Chip market in revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Organ Tumor Chip.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Organ Tumor Chip Market by Company
Axosim Technologies
Beonchip
BioIVT
Emulate
InSphero AG
Mimetas
Nortis
Organovo Holdings
Organ Tumor Chip Segment by Type
Lung Tumor-on-a-chip
Bone Marrow Tumor-on-a-chip
Brain Tumor-on-a-chip
Breast Tumor-on-a-chip
Urinary System Tumor-on-a-chip
Intestine Tumor-on-a-chip
Liver Tumor-on-a-chip
Organ Tumor Chip Segment by Application
Hospital
Laboratory
Organ Tumor Chip Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organ Tumor Chip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organ Tumor Chip and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organ Tumor Chip.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Organ Tumor Chip manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Organ Tumor Chip by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Organ Tumor Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lung Tumor-on-a-chip
- Bone Marrow Tumor-on-a-chip
- Brain Tumor-on-a-chip
- Breast Tumor-on-a-chip
- Urinary System Tumor-on-a-chip
- Intestine Tumor-on-a-chip
- Liver Tumor-on-a-chip
Applications
- Hospital
- Laboratory
Companies covered
- Axosim Technologies
- Beonchip
- BioIVT
- Emulate
- InSphero AG
- Mimetas
- Nortis
- Organovo Holdings
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Organ Tumor Chip by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Lung Tumor-on-a-chip
- 2.2.3 Bone Marrow Tumor-on-a-chip
- 2.2.4 Brain Tumor-on-a-chip
- 2.2.5 Breast Tumor-on-a-chip
- 2.2.6 Urinary System Tumor-on-a-chip
- 2.2.7 Intestine Tumor-on-a-chip
- 2.2.8 Liver Tumor-on-a-chip
- 2.3 Organ Tumor Chip by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Hospital
- 2.3.3 Laboratory
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Organ Tumor Chip Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Organ Tumor Chip Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Organ Tumor Chip Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Organ Tumor Chip Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Organ Tumor Chip Production by Manufacturers (2021-2026)
- 3.2 Global Organ Tumor Chip Production Value by Manufacturers (2021-2026)
- 3.3 Global Organ Tumor Chip Average Price by Manufacturers (2021-2026)
- 3.4 Global Organ Tumor Chip Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Organ Tumor Chip Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Organ Tumor Chip Manufacturers, Product Type & Application
- 3.7 Global Organ Tumor Chip Manufacturers Established Date
- 3.8 Global Organ Tumor Chip Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Axosim Technologies
- 4.1.1 Axosim Technologies Organ Tumor Chip Company Information
- 4.1.2 Axosim Technologies Organ Tumor Chip Business Overview
- 4.1.3 Axosim Technologies Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 4.1.4 Axosim Technologies Product Portfolio
- 4.1.5 Axosim Technologies Recent Developments
- 4.2 Beonchip
- 4.2.1 Beonchip Organ Tumor Chip Company Information
- 4.2.2 Beonchip Organ Tumor Chip Business Overview
- 4.2.3 Beonchip Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 4.2.4 Beonchip Product Portfolio
- 4.2.5 Beonchip Recent Developments
- 4.3 BioIVT
- 4.3.1 BioIVT Organ Tumor Chip Company Information
- 4.3.2 BioIVT Organ Tumor Chip Business Overview
- 4.3.3 BioIVT Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 4.3.4 BioIVT Product Portfolio
- 4.3.5 BioIVT Recent Developments
- 4.4 Emulate
- 4.4.1 Emulate Organ Tumor Chip Company Information
- 4.4.2 Emulate Organ Tumor Chip Business Overview
- 4.4.3 Emulate Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 4.4.4 Emulate Product Portfolio
- 4.4.5 Emulate Recent Developments
- 4.5 InSphero AG
- 4.5.1 InSphero AG Organ Tumor Chip Company Information
- 4.5.2 InSphero AG Organ Tumor Chip Business Overview
- 4.5.3 InSphero AG Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 4.5.4 InSphero AG Product Portfolio
- 4.5.5 InSphero AG Recent Developments
- 4.6 Mimetas
- 4.6.1 Mimetas Organ Tumor Chip Company Information
- 4.6.2 Mimetas Organ Tumor Chip Business Overview
- 4.6.3 Mimetas Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 4.6.4 Mimetas Product Portfolio
- 4.6.5 Mimetas Recent Developments
- 4.7 Nortis
- 4.7.1 Nortis Organ Tumor Chip Company Information
- 4.7.2 Nortis Organ Tumor Chip Business Overview
- 4.7.3 Nortis Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 4.7.4 Nortis Product Portfolio
- 4.7.5 Nortis Recent Developments
- 4.8 Organovo Holdings
- 4.8.1 Organovo Holdings Organ Tumor Chip Company Information
- 4.8.2 Organovo Holdings Organ Tumor Chip Business Overview
- 4.8.3 Organovo Holdings Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 4.8.4 Organovo Holdings Product Portfolio
- 4.8.5 Organovo Holdings Recent Developments
5 Global Organ Tumor Chip Production by Region
- 5.1 Global Organ Tumor Chip Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Organ Tumor Chip Production by Region: 2021-2032
- 5.2.1 Global Organ Tumor Chip Production by Region: 2021-2026
- 5.2.2 Global Organ Tumor Chip Production Forecast by Region (2027-2032)
- 5.3 Global Organ Tumor Chip Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Organ Tumor Chip Production Value by Region: 2021-2032
- 5.4.1 Global Organ Tumor Chip Production Value by Region: 2021-2026
- 5.4.2 Global Organ Tumor Chip Production Value Forecast by Region (2027-2032)
- 5.5 Global Organ Tumor Chip Market Price Analysis by Region (2021-2026)
- 5.6 Global Organ Tumor Chip Production and Value, YOY Growth
- 5.6.1 North America Organ Tumor Chip Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Organ Tumor Chip Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Organ Tumor Chip Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Organ Tumor Chip Production Value Estimates and Forecasts (2021-2032)
- 5.6.5 South Korea Organ Tumor Chip Production Value Estimates and Forecasts (2021-2032)
6 Global Organ Tumor Chip Consumption by Region
- 6.1 Global Organ Tumor Chip Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Organ Tumor Chip Consumption by Region (2021-2032)
- 6.2.1 Global Organ Tumor Chip Consumption by Region: 2021-2026
- 6.2.2 Global Organ Tumor Chip Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Organ Tumor Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Organ Tumor Chip Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Organ Tumor Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Organ Tumor Chip Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Organ Tumor Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Organ Tumor Chip Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Organ Tumor Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Organ Tumor Chip Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Organ Tumor Chip Production by Type (2021-2032)
- 7.1.1 Global Organ Tumor Chip Production by Type (2021-2032) & (k units)
- 7.1.2 Global Organ Tumor Chip Production Market Share by Type (2021-2032)
- 7.2 Global Organ Tumor Chip Production Value by Type (2021-2032)
- 7.2.1 Global Organ Tumor Chip Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Organ Tumor Chip Production Value Market Share by Type (2021-2032)
- 7.3 Global Organ Tumor Chip Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Organ Tumor Chip Production by Application (2021-2032)
- 8.1.1 Global Organ Tumor Chip Production by Application (2021-2032) & (k units)
- 8.1.2 Global Organ Tumor Chip Production Market Share by Application (2021-2032)
- 8.2 Global Organ Tumor Chip Production Value by Application (2021-2032)
- 8.2.1 Global Organ Tumor Chip Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Organ Tumor Chip Production Value Market Share by Application (2021-2032)
- 8.3 Global Organ Tumor Chip Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Organ Tumor Chip Value Chain Analysis
- 9.1.1 Organ Tumor Chip Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Organ Tumor Chip Production Mode & Process
- 9.2 Organ Tumor Chip Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Organ Tumor Chip Distributors
- 9.2.3 Organ Tumor Chip Customers
10 Global Organ Tumor Chip Analyzing Market Dynamics
- 10.1 Organ Tumor Chip Industry Trends
- 10.2 Organ Tumor Chip Industry Drivers
- 10.3 Organ Tumor Chip Industry Opportunities and Challenges
- 10.4 Organ Tumor Chip Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst